← Back to Search

Nicotine Replacement Therapy

John Hopkins Tobacco Treatment Clinic for Quitting Smoking

Phase < 1
Waitlist Available
Led By Mandeep S. Jassal, MD, MPH
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 2 weeks, 1 month, 3 months, 6 months, 9 months and 12 months
Awards & highlights

Summary

This trial is testing a new way to help parents of hospitalized children quit smoking, by providing counseling and education on the risks of secondhand and third hand smoke exposure, as well as information on NRT products.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 2 weeks, 1 month, 3 months, 6 months, 9 months and 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 2 weeks, 1 month, 3 months, 6 months, 9 months and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Self-reported attempts to quit smoking
Secondary outcome measures
Change in Frequency of usage of outpatient tobacco cessation services
Change in Usage of nicotine replacement therapy products

Trial Design

1Treatment groups
Experimental Treatment
Group I: Cessation interventionExperimental Treatment5 Interventions
All participants will receive nicotine replacement therapy and a referral to both Maryland Quitline and Johns Hopkins Tobacco Treatment Clinic for continued cessation care. Nicotine replacement therapy: Nicoderm patches, gum, lozenges Low nicotine dependence: Lozenge (2 mg) or Gum (2 mg) or Patch (7 mg) Moderate nicotine dependence: Patch (14 mg) and Lozenge (2 mg) or Gum (2 mg) High nicotine dependence: Patch (21 mg) and Lozenge (4 mg) or Gum (4 mg) Regardless of the level of nicotine addiction and subsequent dose of nicotine replacement therapy (NRT), participants of this trials are described as "recipients of NRT products".
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Nicotine gum
2015
Completed Phase 4
~2410
Nicotine patch
2015
Completed Phase 4
~6130
Nicotine lozenge
2019
Completed Phase 4
~1940

Find a Location

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor
2,285 Previous Clinical Trials
14,843,065 Total Patients Enrolled
Mandeep S. Jassal, MD, MPHPrincipal InvestigatorJohns Hopkins University
~0 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top